Okyo PharmaOKYO

13F holders, Q2 2026 (June 30)
19holders +7
8new positions
1sold out
1famous investor
$1.50avg. 13F price*

At the end of Q2 2026, 19 institutions reported holding Okyo Pharma Ltd. (OKYO) in their 13F filings, up 7 from Q1 2026. 8 opened new positions and 1 sold out. The largest holders were Woodline Partners LP ($5.5M), Stonepine Capital Management, LLC ($1.3M) and Maven Securities LTD ($1.2M). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).

Company
Okyo Pharma Ltd.
CUSIP
G6724L116
Latest filing quarter
Q2 2026

History

Number of 13F holders

05101520 Q1 2024: 6Q1 2024Q2 2024: 7Q2 2024Q3 2024: 6Q3 2024Q4 2024: 7Q4 2024Q1 2025: 7Q1 2025Q2 2025: 5Q2 2025Q3 2025: 8Q3 2025Q4 2025: 10Q4 2025Q1 2026: 12Q1 2026Q2 2026: 19Q2 2026

Total Exit/New Position Q1 2026 → Q2 2026

InstitutionsTotal Value
New Positions8$704K
Exits1$6K

All 13F filers, Q1 2026 → Q2 2026: 482,960 shares bought and 378,988 shares sold, net +103,972 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 19 holders

Woodline Partners LP 0.02% Add +0.0% 3,652,768 $5.5M
Stonepine Capital Management, LLC 0.99% Add +1.5% 862,996 $1.3M
Maven Securities LTD 0.08% Reduce -31.1% 809,317 $1.2M
Balyasny Asset Management L.P. 0.00% Reduce -0.7% 580,596 $871K
Opaleye Management Inc. 0.05% New 375,204 $563K
UBS Group AG 0.00% Reduce -8.0% 55,009 $83K
XTX Topco Ltd 0.00% Add +0.3% 37,769 $57K
Choreo, LLC 0.00% New 33,255 $50K
Quantinno Capital Management LP 0.00% New 33,255 $50K
Cerity Partners LLC 0.00% No change 12,812 $19K
Geode Capital Management, LLC 0.00% No change 12,090 $18K
Renaissance Technologies 0.00% New 11,200 $17K
Jane Street Group, LLC 0.00% New 10,302 $15K
Steward Partners Investment Advisory, LLC 0.00% New 6,000 $9K
EFG International AG 0.00% No change 923 $1K
Osaic Holdings, Inc. 0.00% No change 152 $228
Continuum Advisory, LLC 0.00% New 50 $75
Morgan Stanley 0.00% No change 10 $15
Caitong International Asset Management Co., Ltd 0.00% New 3 $4

"% of holder's portfolio" is OKYO's weight in each manager's 13F, not the share of Okyo Pharma Ltd. the manager owns.